Arkema, world specialist in specialty chemicals and advanced materials, mandated Natixis as joint active bookrunner and tender agent of the liability management exercise of its hybrid transaction launched in 2014.
Despite an improvement in its credit profile since its previous issuance (rating upgraded to BBB+ by S&P and outlook revised to positive by Moody’s in 2018), Arkema’s aim was to maintain the equity content unchanged. Therefore, with the issuance of the €400m Perpetual nc 5.25 years capital combined with the cash tender offer capped to €400m, Arkema managed proactively its layer of hybrid capital, and concluded an outstanding operation.
This structured transaction evidences Natixis’s expertise recognition and the long-standing relationship with Arkema.
